Jonathan Chou

Also affiliated with UCSF Helen Diller Family Comprehensive Cancer Center

MedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells”.

TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells

European Urology Oncology(2022)10.1016/j.euo.2021.11.005

N/A

3.3DataRank · unranked

88 citations

Kai Trepka, Martin Sjöström, Emily A. Egusa, Carissa Chu, Jun Zhu +14 more

Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2

Cancer Research(2022)10.1158/0008-5472.can-21-4335

N/A

0.884DataRank · unranked

28 citations

Huadong Chen, Yagmur U. Doruk, Tess Williamson, Benjamin J. Polacco, Andrew S. McNeal +13 more

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4175

N/A

0.758DataRank · unranked

156 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Cancer(2021)10.1002/cncr.34057

N/A

0.670DataRank · unranked

86 citations

Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam +31 more

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1123

N/A

0.635DataRank · unranked

68 citations

Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha +58 more

Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1433

N/A

0.621DataRank · unranked

62 citations

Emily A. Egusa, Sinan Wang, Michelle L. Badura, Fei Lee, Anil P. Bidkar +22 more

Theranostic Targeting of CUB Domain–Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-1973

N/A

0.553DataRank · unranked

11 citations

Kai Trepka, Sasank Sakhamuri, Alberto Carretero-González, Jun Zhu, Emily A. Egusa +9 more

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0400

N/A

0.533DataRank · unranked

34 citations

Melissa A. Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y. Feng +17 more

Immunogenic priming with 177Lu-PSMA-617 plus pembrolizumab in metastatic castration resistant prostate cancer (mCRPC): A phase 1b study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5053

N/A

0.524DataRank · unranked

32 citations

Srey Luch Sam, Vadim S. Koshkin, Eric J. Small, Felix Y. Feng, Ivan de Kouchkovsky +12 more

CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3858

N/A

0.515DataRank · unranked

30 citations

Shalini Chopra, Kai Trepka, Yung-Hua Wang, Sasank Sakhamuri, Nima Hooshdaran +18 more

Autoantibody Landscape in Patients with Advanced Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1966

N/A

0.457DataRank · unranked

20 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +26 more

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer

European Urology(2021)10.1016/j.eururo.2021.03.017

N/A

0.449DataRank · unranked

19 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Yang Liu, Jonathan Chou +17 more

Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer

Nature Cancer(2024)10.1038/s43018-024-00848-4

N/A

0.396DataRank · unranked

13 citations

Michelle L. Badura, Patrick C. O’Leary, Henry M. Delavan, Troy M. Robinson, Emily A. Egusa +10 more

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

Nature Communications(2025)10.1038/s41467-025-62710-0

N/A

0.330DataRank · unranked

8 citations

Henry M. Delavan, Elizabeth Yip, Corynn Kasap, Jun Zhu, Roshan Lodha +21 more

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer

Nature Genetics(2025)10.1038/s41588-025-02388-8

N/A

0.312DataRank · unranked

7 citations

James E. Melnyk, Becky Xu Hua Fu, Raunak Shrestha, Meng Zhang, Martin Sjöström +34 more

Large tandem duplications in cancer result from transcription and DNA replication collisions

medRxiv(2023)10.1101/2023.05.17.23290140

N/A

0.301DataRank · unranked

4 citations

Michelle L. Badura, Patrick C. O’Leary, Henry M. Delavan, Troy M. Robinson, Emily A. Egusa +10 more

Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.24

N/A

0.269DataRank · unranked

5 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +14 more

Updated results of phase II trial using escalating doses of neoadjuvant atezolizumab for cisplatin-ineligible patients with nonmetastatic urothelial cancer (NCT02451423).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16510

N/A

0.269DataRank · unranked

5 citations

Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng, Raj S. Pruthi +15 more

Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3310

N/A

0DataRank · unranked

41 citations

Jun Li, Jun Hua, Su Yang, Denis Beckford-Vera, Walter Zhao +20 more

Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer

(2024)10.52843/cassyni.b3jrfx

N/A

0DataRank · unranked

1 citations

Jonathan Chou

Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2850

N/A

0DataRank · unranked

10 citations

Robin Peter, Anju Wadhwa, Kondapa Naidu Bobba, Scott Bidlingmaier, Niranjan Meher +19 more

Identification and Characterization of PLUTO-201, a Novel Long Non-Coding RNA Associated with Poor Outcomes in Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.21.655369

N/A

0DataRank · unranked

0 citations

Noah Younger, Bhavna Malik, Hyun Jin Shin, Chao Zhang, Yashar Niknafs +24 more

Autoantibody landscape of advanced prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.02.074575

N/A

0DataRank · unranked

0 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +25 more

Characterization of PSMA and 18F-fluciclovine transporter gene expression in localized prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.295

N/A

0DataRank · unranked

0 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +15 more

Data from Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2

(2023)10.1158/0008-5472.c.6513989

N/A

0DataRank · unranked

0 citations

Huadong Chen, Yagmur U. Doruk, Tess Williamson, Benjamin J. Polacco, Andrew S. McNeal +13 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730

N/A

0DataRank · unranked

0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730.v1

N/A

0DataRank · unranked

0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Data from Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

(2023)10.1158/1078-0432.c.6529904

N/A

0DataRank · unranked

0 citations

Jun Li, Jun Hua, Yang Su, Denis Beckford-Vera, Walter Zhao +20 more